Outreach Labs Remain Profitable Despite Antiquated Systems & Lack of Exec Respect

Hidden within the basement of your average hospital is a $24 million business, one that provides a top quality, must-have service and operates at a margin of around 25% to 30%. That business is the … [Read more...]


FDA Watch: New Moves to Boost CLIA Transparency

The CLIA standards that a lab must meet are based on the complexity of the in vitro diagnostic tests it performs. The FDA's primary role in the CLIA system is to categorize IVDs. Test … [Read more...]


Industry Trends: New Report Sheds Light on DX Tech Capital Flows

The health care industry has raised $5 billion in venture fund investment in the first half of 2017 and is well on pace to smash the single year record of $7.5 billion set in 2015, according to … [Read more...]


Draft 2018 CLFS Reveals Fundamental Flaws in PAMA Reporting Exercise; Time to Take Action

By Lâle White  bio As XIFIN predicted, the PAMA reporting exercise has resulted in significant proposed laboratory fee cuts. In fact, the multi-year decrease for the top 20 laboratory tests … [Read more...]


Company of the Month: Interpace Diagnostics

Question: What do Parsippany, NJ-based Interpace Diagnostics and butter have in common? Answer: They're both on a roll. July 27: The molecular lab announces that Cigna will cover its ThyGenX … [Read more...]


Medicare Reimbursement: 4 Molecular Assays Score Big Coverage Wins

Molecular labs continue to gain ground with Medicare securing four key approvals via finalization of Local Coverage Determinations (LCDs) issued by principal contractor Palmetto GBA this spring. All … [Read more...]


Inside the Lab Industry: The Surge of Do-It-Yourself Test Kits

Consumerism, patient empowerment and affordability are key drivers in the modern medical industry. One of the key manifestations of this within the clinical laboratories sector is the rapid growth of … [Read more...]


Industry Buzz: The Diagnostic Market’s M&A Highlights from 1H 2017

As usual, the Big 3 of Abbott, Quest and LabCorp were the driving force of M&A activity in the diagnostics industry in the first half of 2017. Abbott Continues to Make News Each company … [Read more...]


Ordering Physicians: Oncologists Say Genomic Testing Is Overhyped

When it comes to measuring Dx product effectiveness, few things speak louder than the attitudes of ordering physicians. With that in mind, genomic test manufacturers might want to take pause from a … [Read more...]


Focus On: Quest-Walmart Deal Latest in Mass Retailing of Lab Tests

Laboratory test products have been appearing on the shelves of mass retail stores with growing frequency. But the newly announced partnership between Walmart and Quest Diagnostics raises eyebrows … [Read more...]